EVF: 1,3-benzothiazole-2-sulfonamide
EVF is a Ligand Of Interest in 5JG5 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5JG5_EVF_B_301 | 97% | 33% | 0.081 | 0.994 | 0.96 | 1.65 | - | 3 | 0 | 0 | 100% | 1 |
| 5JG5_EVF_B_302 | 87% | 18% | 0.106 | 0.977 | 0.96 | 2.54 | 1 | 6 | 1 | 0 | 100% | 0.58 |
| 5JDV_EVF_B_302 | 99% | 27% | 0.063 | 0.994 | 0.95 | 1.95 | - | 7 | 0 | 0 | 100% | 1 |
| 5JEG_EVF_B_302 | 98% | 17% | 0.065 | 0.991 | 1.07 | 2.52 | - | 4 | 0 | 0 | 100% | 0.78 |
| 5JG3_EVF_B_301 | 98% | 22% | 0.066 | 0.992 | 1.28 | 1.95 | 1 | 6 | 0 | 0 | 100% | 1 |
| 5JEP_EVF_B_302 | 98% | 27% | 0.07 | 0.995 | 1.12 | 1.8 | 1 | 5 | 0 | 0 | 100% | 1 |
| 5JE7_EVF_B_302 | 98% | 28% | 0.07 | 0.994 | 0.99 | 1.85 | 1 | 5 | 0 | 0 | 100% | 1 |
